InSphero at ACT 2026
Nov 15–18, 2026 San Antonio, TX ~1.4k attendees Website
InSphero takes part in 3 sessions at ACT 2026 in San Antonio, and exhibits at Booth 103. Its program centres on human 3D liver microtissues for early safety testing, including AI-assisted prediction of drug-induced liver injury anchored to drug exposure. It also covers low-input RNA sequencing to compare liver effects across species and related compounds, plus its liver and gut models.
| Organization | ACT 2026 Attendance |
|---|---|
InSphero Brunswick, ME | |
Makes 3D spheroid microtissue models, such as liver and gastrointestinal models, for in vitro safety and efficacy testing in drug discovery. | Booth Exhibiting at Booth 103 Mon, Nov 169:30am–6:30pmTue, Nov 178:00am–4:30pm Poster Mon Nov 16 5:00pm–6:30pm Talk Tue Nov 17 9:55am–10:15am Talk Wed Nov 18 12:00pm–12:55pm |
Instantly find 20 buyers from InSphero
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American College of Toxicology (ACT). Organization details are derived from ACT’s published program, exhibitor floor plan and supporter list, and each organization’s own website. Submit a correction